Literature DB >> 25767100

ERAP1 biology and assessment in Ankylosing Spondylitis.

Philip C Robinson1, Matthew A Brown2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25767100      PMCID： PMC4403178          DOI： 10.1073/pnas.1501475112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  5 in total

1.  The aminopeptidase ERAAP shapes the peptide repertoire displayed by major histocompatibility complex class I molecules.

Authors:  Gianna Elena Hammer; Federico Gonzalez; Marine Champsaur; Dragana Cado; Nilabh Shastri
Journal:  Nat Immunol       Date:  2005-11-20       Impact factor: 25.606

2.  The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues.

Authors:  Ian A York; Shih-Chung Chang; Tomo Saric; Jennifer A Keys; Janice M Favreau; Alfred L Goldberg; Kenneth L Rock
Journal:  Nat Immunol       Date:  2002-11-18       Impact factor: 25.606

3.  Functionally distinct ERAP1 allotype combinations distinguish individuals with Ankylosing Spondylitis.

Authors:  Emma Reeves; Alexandra Colebatch-Bourn; Tim Elliott; Christopher J Edwards; Edward James
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-24       Impact factor: 11.205

4.  Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility.

Authors:  David M Evans; Chris C A Spencer; Jennifer J Pointon; Zhan Su; David Harvey; Grazyna Kochan; Udo Oppermann; Udo Opperman; Alexander Dilthey; Matti Pirinen; Millicent A Stone; Louise Appleton; Loukas Moutsianas; Loukas Moutsianis; Stephen Leslie; Tom Wordsworth; Tony J Kenna; Tugce Karaderi; Gethin P Thomas; Michael M Ward; Michael H Weisman; Claire Farrar; Linda A Bradbury; Patrick Danoy; Robert D Inman; Walter Maksymowych; Dafna Gladman; Proton Rahman; Ann Morgan; Helena Marzo-Ortega; Paul Bowness; Karl Gaffney; J S Hill Gaston; Malcolm Smith; Jacome Bruges-Armas; Ana-Rita Couto; Rosa Sorrentino; Fabiana Paladini; Manuel A Ferreira; Huji Xu; Yu Liu; Lei Jiang; Carlos Lopez-Larrea; Roberto Díaz-Peña; Antonio López-Vázquez; Tetyana Zayats; Gavin Band; Céline Bellenguez; Hannah Blackburn; Jenefer M Blackwell; Elvira Bramon; Suzannah J Bumpstead; Juan P Casas; Aiden Corvin; Nicholas Craddock; Panos Deloukas; Serge Dronov; Audrey Duncanson; Sarah Edkins; Colin Freeman; Matthew Gillman; Emma Gray; Rhian Gwilliam; Naomi Hammond; Sarah E Hunt; Janusz Jankowski; Alagurevathi Jayakumar; Cordelia Langford; Jennifer Liddle; Hugh S Markus; Christopher G Mathew; Owen T McCann; Mark I McCarthy; Colin N A Palmer; Leena Peltonen; Robert Plomin; Simon C Potter; Anna Rautanen; Radhi Ravindrarajah; Michelle Ricketts; Nilesh Samani; Stephen J Sawcer; Amy Strange; Richard C Trembath; Ananth C Viswanathan; Matthew Waller; Paul Weston; Pamela Whittaker; Sara Widaa; Nicholas W Wood; Gilean McVean; John D Reveille; B Paul Wordsworth; Matthew A Brown; Peter Donnelly
Journal:  Nat Genet       Date:  2011-07-10       Impact factor: 38.330

5.  Balancing selection maintains a form of ERAP2 that undergoes nonsense-mediated decay and affects antigen presentation.

Authors:  Aida M Andrés; Megan Y Dennis; Warren W Kretzschmar; Jennifer L Cannons; Shih-Queen Lee-Lin; Belen Hurle; Pamela L Schwartzberg; Scott H Williamson; Carlos D Bustamante; Rasmus Nielsen; Andrew G Clark; Eric D Green
Journal:  PLoS Genet       Date:  2010-10-14       Impact factor: 5.917
  5 in total
  6 in total

Review 1.  Genetics and the Causes of Ankylosing Spondylitis.

Authors:  Aimee Hanson; Matthew A Brown
Journal:  Rheum Dis Clin North Am       Date:  2017-08       Impact factor: 2.670

2.  Reply to Robinson and Brown: It is the combination of ERAP1 allotypes that identifies individuals with Ankylosing Spondylitis.

Authors:  Emma Reeves; Alexandra Colebatch-Bourn; Tim Elliott; Christopher J Edwards; Edward James
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-12       Impact factor: 11.205

Review 3.  Genetics of antigen processing and presentation.

Authors:  Adrian Kelly; John Trowsdale
Journal:  Immunogenetics       Date:  2018-09-13       Impact factor: 2.846

Review 4.  M1 aminopeptidases as drug targets: broad applications or therapeutic niche?

Authors:  Nyssa Drinkwater; Jisook Lee; Wei Yang; Tess R Malcolm; Sheena McGowan
Journal:  FEBS J       Date:  2017-02-03       Impact factor: 5.542

5.  An allelic variant in the intergenic region between ERAP1 and ERAP2 correlates with an inverse expression of the two genes.

Authors:  Fabiana Paladini; Maria Teresa Fiorillo; Carolina Vitulano; Valentina Tedeschi; Matteo Piga; Alberto Cauli; Alessandro Mathieu; Rosa Sorrentino
Journal:  Sci Rep       Date:  2018-07-10       Impact factor: 4.379

6.  PSA controls hepatic lipid metabolism by regulating the NRF2 signaling pathway.

Authors:  Bangliang Huang; Xin Xiong; Linlin Zhang; Xiufei Liu; Yuren Wang; Xiaoli Gong; Qian Sang; Yongling Lu; Hua Qu; Hongting Zheng; Yi Zheng
Journal:  J Mol Cell Biol       Date:  2021-10-21       Impact factor: 6.216
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.